4.8 Article

A p53-dependent checkpoint pathway prevents rereplication

Journal

MOLECULAR CELL
Volume 11, Issue 4, Pages 997-1008

Publisher

CELL PRESS
DOI: 10.1016/S1097-2765(03)00099-6

Keywords

-

Funding

  1. NCI NIH HHS [R01 CA60499] Funding Source: Medline
  2. NIEHS NIH HHS [R01 ES009558] Funding Source: Medline

Ask authors/readers for more resources

Eukaryotic cells control the initiation of DNA replication so that origins that have fired once in S phase do not fire a second time within the same cell cycle. Failure to exert this control leads to genetic instability. Here we investigate how rereplication is prevented in normal mammalian cells and how these mechanisms might be overcome during tumor progression. Overexpression of the replication initiation factors Cdt1 and Cdc6 along with cyclin A-cdk2 promotes rereplication in human cancer cells with inactive p53 but not in cells with functional p53. A subset of origins distributed throughout the genome refire within 2-4 hr of the first cycle of replication. Induction of rereplication activates p53 through the ATM/ATR/Chk2 DNA damage checkpoint pathways. p53 inhibits rereplication through the induction of the cdk2 inhibitor p21. Therefore, a p53-dependent checkpoint pathway is activated to suppress rereplication and promote genetic stability.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available